This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX Europe
Life Science Fundraising & Investment
25-26 March 2026 - Main days, Lisbon Congress Centre, Lisbon, Portugal24 March 2026 - Pre-day forums (Life Science Companies only), FIL (Feira Internacional de Lisboa)
Menu
keyboard_arrow_right

Day Two - Western European Summer Time (WEST)

keyboard_arrow_leftSearch & Filter
search
Day Two - Western European Summer Time (WEST)
search
Showing 1 of 1 Streams
09:00 - 09:05
LSX Welcome Address: Biotech Leaders
  • Adam Griffiths - Portfolio Manager, LSX
09:05 - 09:35
State of Biotech Markets: A Forward-looking View
  • Cody Powers - Partner, ZS Associates
09:35 - 10:30
Investment, Innovation, and Influence: Reimagining Europe’s Role in Global Life Sciences
  • Adam Schoen - Partner, Brown Rudnick
  • Zina Affas Besse - Partner and Deputy Head of Healthcare Private Equity, BNP Paribas Asset Management
  • Giovanni Mariggi - Partner, Medicxi
  • Holger Kissel - SVP Scientific Relations & Liaison, BioNtech
  • Mary Clark - CEO, Optimum Strategic Communications
Showing 1 of 1 Streams
16:20 - 17:00
Biotech’s Next Frontier: Unlocking the Future of Early-Stage Funding
  • Roel Bulthuis - Managing Partner, Head of Investments, Syncona
  • Arno de Wilde - Managing Director, EQT Life Sciences
  • Josh Little - Senior Associate, M&A, A&O Shearman
  • Tobias Horneman-Thielcke - Partner, Eir Ventures
  • Hans T. Schambye - CEO, BOOST Pharma
  • Megan McMellon - Senior Associate, Commercial IP, A&O Shearman
17:00 - 17:40
Strategic Pharma Business Development: M&A and Beyond
  • Melanie Howard - Partner, Latham & Watkins
  • Chloé Leprêtre - Head of Global R&D Search & Evaluation, Servier
  • Stefano Cottignoli - SVP, Head of Global Business & Corporate Development, Chiesi Group
  • Daniel Abernathy - Director, McQuade Center for Strategic Research & Development, Otsuka
  • Caroline Austin - VP, Head of Transactions, Business Development, AstraZeneca
Day One - Pre-Day
NextDay Two Showcases
Filter
Streams
Clear
Formats
Choose Day